Answers are grounded in this paper and cite their sources.
Sweating is essential for thermoregulation and skin homeostasis, and depends on coordinated neural signaling and ion transport in eccrine glands in humans. A central component of this process is the Ca²⁺-activated chloride channel anoctamin 1 (ANO1), which mediates Cl⁻ efflux into the gland lumen following intracellular Ca²⁺ elevation, thereby driving osmotic fluid secretion. Transient receptor potential vanilloid 4 (TRPV4), a temperature-sensitive cation channel expressed in sweat gland acinar cells, contributes to this process by promoting Ca²⁺ influx and activating ANO1. In this study, we first found that l -menthol, which we previously reported to inhibit ANO1 and reduce sweating, inhibits TRPV4 activity, suggesting that blocking TRPV4 and ANO1 both of which were known to make a complex for exocrine function with water efflux is effective for inhibition of perspiration. Then we searched for the new compounds inhibiting both TRPV4 and ANO1, and focused on crotamiton, a topical antipruritic agent known to inhibit TRPV4. Using a whole-cell patch-clamp technique, we found that crotamiton inhibits ANO1-mediated currents. We also demonstrated that crotamiton suppresses sweating in both mice and humans while blocking of either TRPV4 or ANO1 alone was not sufficient for the significant inhibition of sweating in mice. These results indicate that compounds targeting both TRPV4 and ANO1 would be a promising strategy to develop effective antiperspirants.
No takes yet. Share an insight, caveat, or question.
Iwata et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: